GlassScriptPhysician profile
Suzanne Araujo
NPI 1417620386
$2,425.23
in general payments reported to CMS, 2019-2025
24 companies · $15.49 in 2025
The $15.49 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,476 · 2023: $934 · 2025: $15.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $381.12 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $325.53 | 2022-2023 | Breztri, Fasenra, Farxiga |
| Novo Nordisk INC | $222.99 | 2022-2023 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $176.84 | 2022-2023 | Rexulti |
| Sanofi-Aventis U.S. LLC | $153.33 | 2022-2023 | |
| Xeris Pharmaceuticals, INC. | $145.85 | 2022-2023 | Gvoke Hypopen |
| Nestle Healthcare Nutrition INC. | $122.47 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $101.70 | 2022-2023 | |
| Abbvie INC. | $90.42 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.66 | 2022-2023 | Xifaxan, Ibschek |
| Lilly USA, LLC | $77.28 | 2022-2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $64.51 | 2022-2025 | Vaxelis, Vaqta, Gardasil 9 |
| Pfizer INC. | $61.64 | 2022-2023 | |
| Amgen INC. | $58.82 | 2022 | |
| Glaxosmithkline, LLC. | $58.28 | 2022-2023 | Trelegy Ellipta |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.94 | 2022 | |
| Vanda Pharmaceuticals INC. | $47.48 | 2022 | |
| Exact Sciences Corporation | $44.72 | 2023 | Cologuard Collection Kit |
| Scynexis, INC. | $39.90 | 2022 | |
| Hologic Sales and Service, LLC | $23.68 | 2022 | |
| Amarin Pharma, INC. | $23.10 | 2022 | |
| Shield Therapeutics INC | $22.87 | 2023 | Accrufer |
| Mylan Specialty L.P. | $22.28 | 2022 | |
| Lifescan, INC. | $20.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Araujo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.